A genetics doctor maps your family history of dementia and estimates risk for you and your relatives. A genetics doctor is a clinician with special training in inherited risk, gene testing, and family counseling.
If several relatives had Alzheimer's, especially at younger ages, that visit can guide clear next steps. It does not diagnose dementia. It shows whether your pattern looks inherited and whether testing would help.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What happens during the genetics visit?
- How will they read your family pattern?
- Which gene changes matter most?
- Who is offered diagnostic testing?
- What does counseling cover before you decide?
What happens during the genetics visit?
The clinician builds a detailed family tree covering at least three generations. According to the National Society of Genetic Counselors, that pedigree records dementia type, age of onset, and how each diagnosis was made in the NSGC pedigree guideline. It also records current ages or ages and causes of death.
The clinician confirms diagnoses from medical records when possible. Bring names, relationships, and health details if you have them. Useful items include:.
- dementia type or symptoms for each affected relative
- age when symptoms began and how doctors diagnosed it
- current age, or age and cause of death, for close relatives
How will they read your family pattern?
The clinician combines that tree with your own medical history. The UCSF Memory and Aging Center describes this step as sorting families into autosomal-dominant early-onset, familial, or sporadic Alzheimer's patterns to estimate relatives' risk.
Family history raises concern without settling it. The Alzheimer's Association notes that a parent or sibling with Alzheimer's makes disease more likely, especially with several affected close relatives. It also notes that family history alone neither predicts nor is required for disease.
Which gene changes matter most?
Rare changes in APP, PSEN1, or PSEN2 cause early-onset familial Alzheimer's. As described by MedlinePlus Genetics, inheritance is autosomal-dominant, so a child of a carrier has a 50% chance of inheriting the mutation in the MedlinePlus genetics overview. These families often show symptoms well before age 65 and across generations.
The more common risk variant is APOE-e4, linked to late-onset Alzheimer's. According to the dementia.co.uk review, it is the strongest common risk variant yet neither necessary nor sufficient, since many carriers stay healthy and many patients lack it in the late-onset risk review. Joint ACMG and NSGC guidance does not recommend APOE testing for routine care because predictive value is low.
Who is offered diagnostic testing?
Testing is selective, not routine. NSGC guidance reserves it for symptomatic early-onset disease with family history, families showing autosomal-dominant early-onset disease, or families with a known APP, PSEN1, or PSEN2 mutation. Doctors prefer to test an affected relative first or store DNA for later use.
This approach avoids unclear results in people with low prior risk. A negative test in an unaffected person means little when the family mutation is unknown. A positive APOE result also cannot confirm future dementia.
What does counseling cover before you decide?
Counseling explains test limits and what positive, negative, or uncertain results would mean for you and relatives. It covers cascade testing for at-risk relatives, effects on insurance and life planning, family planning options, and psychological support.
For people considering anti-amyloid treatment, it also addresses higher ARIA risk with APOE-e4 homozygosity. Ask for a written summary you can share with family and your care team.





